Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Non Operating Income (2021 - 2026)

HeartSciences (HSCS) has disclosed Non Operating Income for 5 consecutive years, with -$277366.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income fell 183.36% year-over-year to -$277366.0, compared with a TTM value of -$796992.0 through Oct 2025, down 402.17%, and an annual FY2025 reading of -$412658.0, down 37.81% over the prior year.
  • Non Operating Income was -$277366.0 for Q4 2025 at HeartSciences, down from -$180875.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $172595.0 in Q3 2021 and bottomed at -$277366.0 in Q4 2025.
  • Average Non Operating Income over 5 years is -$85029.1, with a median of -$87899.5 recorded in 2021.
  • The sharpest move saw Non Operating Income surged 199.77% in 2024, then tumbled 854.34% in 2025.
  • Year by year, Non Operating Income stood at -$77914.0 in 2021, then soared by 59.43% to -$31606.0 in 2022, then tumbled by 464.56% to -$178435.0 in 2023, then soared by 45.14% to -$97885.0 in 2024, then crashed by 183.36% to -$277366.0 in 2025.
  • Business Quant data shows Non Operating Income for HSCS at -$277366.0 in Q4 2025, -$180875.0 in Q3 2025, and -$173931.0 in Q2 2025.